ELEV Insider Trading

83.70% of Elevation Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Elevation Oncology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/11/2024	Vanguard Group Inc.	1,171,246	$0.63M	0.0%	+9.5%	2.407%
2/15/2024	Vanguard Group Inc.	1,171,246	$0.63M	0.0%	+9.5%	2.761%
2/15/2024	Citadel Advisors LLC	591,483	$0.32M	0.0%	-29.6%	1.395%
11/21/2023	Walleye Capital LLC	148,887	$99K	0.0%	+43.7%	0.351%
11/15/2023	Armistice Capital LLC	750,000	$0.50M	0.0%	-68.7%	1.768%
11/9/2023	UBS Group AG	124,561	$83K	0.0%	+674.7%	0.294%
8/15/2023	Walleye Capital LLC	103,630	$0.16M	0.0%	-76.1%	0.245%
8/15/2023	venBio Partners LLC	2,914,255	$4.43M	1.6%	+56.1%	6.876%
8/15/2023	Point72 Asset Management L.P.	400,000	$0.61M	0.0%	N/A	0.944%
8/15/2023	Sphera Funds Management LTD.	900,000	$1.37M	0.2%	N/A	2.124%
8/15/2023	Hudson Bay Capital Management LP	546,294	$0.83M	0.0%	N/A	1.289%
8/15/2023	Boothbay Fund Management LLC	234,266	$0.36M	0.0%	N/A	0.553%
8/15/2023	Caxton Corp	21,725	$33K	0.1%	-68.2%	0.051%
8/15/2023	Citadel Advisors LLC	838,594	$1.28M	0.0%	N/A	1.979%
8/14/2023	Schonfeld Strategic Advisors LLC	134,100	$0.20M	0.0%	N/A	0.316%
8/11/2023	Renaissance Technologies LLC	16,800	$26K	0.0%	-67.4%	0.040%
8/11/2023	Velan Capital Investment Management LP	497,299	$0.76M	0.7%	N/A	1.173%
8/11/2023	ExodusPoint Capital Management LP	1,499,319	$2.28M	0.0%	N/A	6.160%
5/18/2023	JPMorgan Chase & Co.	22,347	$42K	0.0%	+427.1%	0.092%
5/16/2023	State Street Corp	42,100	$80K	0.0%	+127.6%	0.177%
5/16/2023	Geode Capital Management LLC	130,380	$0.25M	0.0%	+44.3%	0.548%
5/15/2023	Two Sigma Investments LP	73,958	$0.14M	0.0%	N/A	0.311%
5/15/2023	Sio Capital Management LLC	876,611	$1.67M	0.8%	+143.7%	3.685%
5/12/2023	Renaissance Technologies LLC	51,500	$98K	0.0%	-74.2%	0.217%
5/12/2023	BlackRock Inc.	32,751	$62K	0.0%	-12.8%	0.138%
5/1/2023	Virtu Financial LLC	27,286	$52K	0.0%	N/A	0.115%
2/15/2023	Annandale Capital LLC	50,000	$48K	0.0%	+66.7%	0.215%
2/15/2023	Tang Capital Management LLC	479,854	$0.46M	0.1%	N/A	2.059%
2/13/2023	BML Capital Management LLC	39,963	$38K	0.0%	N/A	0.172%
2/13/2023	Renaissance Technologies LLC	199,900	$0.19M	0.0%	-30.7%	0.858%
11/15/2022	Vanguard Group Inc.	333,024	$0.38M	0.0%	-16.9%	1.429%
11/14/2022	Annandale Capital LLC	30,000	$34K	0.0%	N/A	0.129%
11/14/2022	Cormorant Asset Management LP	1,952,032	$2.21M	0.2%	-1.6%	8.377%
11/14/2022	Renaissance Technologies LLC	288,657	$0.33M	0.0%	+11.7%	1.239%
8/16/2022	venBio Partners LLC	1,866,339	$2.61M	0.7%	-28.4%	8.013%
8/15/2022	Millennium Management LLC	21,573	$30K	0.0%	N/A	0.093%
8/13/2022	Virtu Financial LLC	21,798	$31K	0.0%	N/A	0.094%
8/13/2022	Renaissance Technologies LLC	258,400	$0.36M	0.0%	+917.3%	1.110%
8/10/2022	Kennedy Capital Management Inc.	149,893	$0.21M	0.0%	+968.4%	0.644%
5/13/2022	Renaissance Technologies LLC	25,400	$64K	0.0%	+53.0%	0.109%
5/13/2022	Vanguard Group Inc.	376,153	$0.95M	0.0%	-1.2%	1.618%
5/12/2022	BlackRock Inc.	38,218	$96K	0.0%	+57.4%	0.164%
4/26/2022	Marquette Asset Management LLC	38,951	$98K	0.0%	+332.5%	0.168%
4/25/2022	Bailard Inc.	23,500	$59K	0.0%	N/A	0.101%
2/18/2022	TCG Crossover Management LLC	555,000	$3.34M	1.6%	N/A	2.389%
2/15/2022	Kennedy Capital Management Inc.	15,485	$93K	0.0%	N/A	0.067%
2/14/2022	Boxer Capital LLC	872,780	$5.25M	0.2%	-34.9%	3.758%
2/14/2022	Sio Capital Management LLC	250,000	$1.51M	0.5%	N/A	1.076%
1/19/2022	Marquette Asset Management LLC	9,006	$54K	0.0%	N/A	0.039%
11/16/2021	Schonfeld Strategic Advisors LLC	18,044	$0.14M	0.0%	-29.8%	0.078%
11/16/2021	Janus Henderson Group PLC	1,220,205	$9.38M	0.0%	+18.3%	5.254%
11/16/2021	Caxton Corp	48,183	$0.38M	0.3%	+21.7%	0.207%
11/9/2021	BlackRock Inc.	23,837	$0.19M	0.0%	N/A	0.103%
8/17/2021	Weiss Multi Strategy Advisers LLC	15,037	$0.20M	0.0%	N/A	0.066%
8/17/2021	Woodline Partners LP	112,431	$1.53M	0.0%	N/A	0.493%
8/17/2021	Samsara BioCapital LLC	932,239	$12.65M	1.6%	N/A	4.085%
8/17/2021	Sphera Funds Management LTD.	30,000	$0.41M	0.0%	N/A	0.131%
8/17/2021	Millennium Management LLC	123,062	$1.67M	0.0%	N/A	0.539%
8/17/2021	BVF Inc. IL	1,590,291	$21.58M	0.8%	N/A	6.968%
8/17/2021	Boxer Capital LLC	1,341,530	$18.21M	0.6%	N/A	5.878%
8/17/2021	Caas Capital Management LP	60,000	$0.81M	0.0%	N/A	0.263%
8/17/2021	Caxton Corp	39,586	$0.54M	0.4%	N/A	0.173%
8/16/2021	LMR Partners LLP	31,300	$0.43M	0.0%	N/A	0.137%
8/16/2021	Point72 Asset Management L.P.	50,000	$0.68M	0.0%	N/A	0.219%
8/16/2021	venBio Partners LLC	2,608,167	$35.39M	4.2%	N/A	11.428%
8/16/2021	Alyeska Investment Group L.P.	125,000	$1.70M	0.0%	N/A	0.548%
8/16/2021	Schonfeld Strategic Advisors LLC	25,700	$0.35M	0.0%	N/A	0.113%
8/16/2021	Pinz Capital Management LP	36,400	$0.49M	0.1%	N/A	0.159%
8/16/2021	Maven Securities LTD	16,000	$0.20M	0.0%	N/A	0.070%
8/16/2021	Goldman Sachs Group Inc.	62,500	$0.85M	0.0%	N/A	0.274%
8/13/2021	Northern Trust Corp	4,803	$65K	0.0%	N/A	0.021%
8/13/2021	Qube Research & Technologies Ltd	24,255	$0.33M	0.0%	N/A	0.106%
8/13/2021	Vanguard Group Inc.	60,000	$0.81M	0.0%	N/A	0.263%
8/12/2021	Monashee Investment Management LLC	140,000	$1.90M	0.2%	N/A	0.613%
8/11/2021	Ghost Tree Capital LLC	100,000	$1.36M	0.4%	N/A	0.438%

Data available starting January 2016

Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs. The company's lead candidate is EO-3021, an antibody-drug conjugate designed to target Claudin 18.2, a clinically validated molecular target. Its EO-3021 selectively delivers a cytotoxic payload directly to cancer cells expressing Claudin 18.2. Elevation Oncology, Inc. has a license agreement with CSPC Megalith Biopharmaceutical Co., Ltd. to develop and commercialize EO-3021. The company was formerly known as 14ner Oncology, Inc. and changed its name to Elevation Oncology, Inc. in February 2020. The company was incorporated in 2019 and is based in New York, New York.

Today's Range

Now: $4.39

$4.15

$4.52

50 Day Range

MA: $4.09

$2.56

$5.17

52 Week Range

Now: $4.39

$0.36

$5.89

Volume

763,156 shs

Average Volume

2,777,602 shs

Market Capitalization

$213.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.34

Who are the company insiders with the largest holdings of Elevation Oncology?: Elevation Oncology's top insider shareholders include:
Global Strategic Fund I Venbio (Major Shareholder)
Learn More about top insider investors at Elevation Oncology.